...
首页> 外文期刊>Journal of clinical densitometry >FRAX Score Can Be Used to Avoid Superfluous DXA Scans in Detecting Osteoporosis in Celiac Disease: Accuracy of the FRAX Score in Celiac Patients
【24h】

FRAX Score Can Be Used to Avoid Superfluous DXA Scans in Detecting Osteoporosis in Celiac Disease: Accuracy of the FRAX Score in Celiac Patients

机译:Frax得分可用于避免多余的DXA扫描检测腹腔病的骨质疏松症:乳糜泻患者的骨草评分的准确性

获取原文
获取原文并翻译 | 示例
           

摘要

The Fracture Risk Assessment (FRAX) tool has been developed to estimate patients' 10-yr probability of fracture, thus establishing which patients should undergo dual-energy X-ray Absorptiometry (DXA) scan. This study aimed to evaluate if the FRAX tool can replace or optimize the use of DXA scan in celiac disease (CD). We prospectively enrolled all CD patients aged over 40?yr diagnosed at our third-level unit. At time of CD diagnosis, all patients underwent FRAX score calculation for risk of major osteoporotic and hip fractures and DXA scan (used asgold standard) to assess the accuracy of the FRAX score. The FRAX score calculation was based on the following 10 variables: age (>40?yr), sex (M/F), body mass index, history of previous fracture (yes/no), parent fractured hip (yes/no), current smoking (yes/no), use of steroids (yes/no), rheumatoid arthritis (yes/no), secondary osteoporosis (yes/no), and alcohol?≥3 units/d (yes/no). DXA assessment was performed within 1 week from FRAX calculation. The FRAX score was dichotomized as normal or pathologic in accordance with the National Osteoporosis Guideline Group. A total of 160 CD patients were enrolled (M/F?=?20/140; mean age 48.7?yr). A pathologic FRAX score was evident in 14 out of 160 patients (8.7%), whereas osteoporosis based on DXA scan was found in 10 patients (6%) (κ?=?0.6); 3 patients with osteoporosis (1.9%) showed a 10-yr risk of major fracture >10% according to the National Osteoporosis Guideline Group criteria. With regard to diagnostic accuracy, the FRAX score showed sensitivity of 0%, specificity of 91%, positive predictive value of 0%, and negative predictive value of 94%. The prevalence of osteoporosis in adult CD appears to be quite low and only a small proportion of patients would require a DXA investigation. The FRAX score could be an effective tool to avoid useless DXA scans in CD patients in view of its high negative predictive value.
机译:已经开发出骨折风险评估(FRAX)工具来估计患者的骨折10年的概率,从而建立哪些患者应经过双能X射线吸收测定法(DXA)扫描。本研究旨在评估FRAX工具是否可以替代或优化DXA扫描在腹腔疾病(CD)中的使用。我们展示了在我们的第三级单位诊断出40多名超过40岁的CD患者。在CD诊断时,所有患者都接受了Frax评分计算,用于主要骨质疏松症和髋关节骨折和DXA扫描(二手ASGold标准)的风险,以评估Frax评分的准确性。 FAX得分计算基于以下10个变量:年龄(> 40?YR),性别(M / F),体重指数,先前骨折的历史(是/否),父母骨折臀部(是/否),目前的吸烟(是/否),使用类固醇(是/否),类风湿性关节炎(是/否),二级骨质疏松症(是/否)和酒精?≥3个单位/ D(是/否)。 DXA评估从Frax计算后1周内进行。根据国家骨质疏松指南组,Frax评分与正常或病态分解为正常或病理。共有160名CD患者(M / F?= 20/140;平均年龄48.7?YR)。在160名患者中的14名(8.7%)中,病理十五分数明显,而基于DXA扫描的骨质疏松症在10名患者中发现(6%)(κα=?0.6); 3例骨质疏松症患者(1.9%)显示了10岁的主要骨折风险> 10%根据国家骨质疏松指南群标准。关于诊断准确性,FAX得分显示敏感性为0%,特异性为91%,阳性预测值为0%,负预测值为94%。成人CD中骨质疏松症的患病率似乎相当低,只有小比例患者需要DXA调查。鉴于其高负预测值,FAX得分可能是避免无用的DXA扫描的有效工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号